Alliance Research Grant Program
Forecasted
Alliance Research Grant Program supports investigators and research teams pursuing preclinical, translational, and early clinical colorectal cancer research to advance new treatments and survivorship.
Browse similar grants
Funder: Colorectal Cancer Alliance
Due Dates: Later in 2026 (RFP reopening anticipated; date not set)
Funding Amounts: Up to $200,000–$500,000 over two years, depending on award category
Summary: Supports preclinical, translational, early clinical, and collaborative research toward new colorectal cancer treatments.
Key Information: The RFP is temporarily suspended while the Alliance focuses on an adaptive clinical trial platform.
Description
The Colorectal Cancer Alliance runs the Alliance Research Grant Program through Project Cure CRC. Its accelerator awards support original early-stage investigations, research on therapies for localized or metastatic colorectal cancer, high-risk proof-of-concept studies, and multidisciplinary teams working to move innovations toward patients.
The program prioritizes research that could accelerate colorectal cancer treatment and survivorship, particularly new therapies and technologies with curative potential. The Alliance has temporarily suspended its request for proposals while it establishes an adaptive clinical trial platform under Project Cure CRC. Future research funding depends on available resources and alignment with that priority.
